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Introduction
There is strong evidence that most psychiatric disorders
have their origins early in life and that risk for psychiatric
disorders in adulthood is increased by childhood adversities
[1]. Furthermore, neuropsychiatric disorders are the most
common causes of burden and disability in young persons
aged 10–24 years in whom they account for 45 % of these,
and are strongly associated with risk-behaviors and sub-
stantial psychosocial impairment [2–5]. An important
concern is the duration of untreated illness which has been
increasingly considered as a predictor of worse outcome
across different psychiatric disorders [6]. Therefore, an
early detection and adequate intervention are crucial to
reduce overall burden and disability associated with neu-
ropsychiatric disorders [7]. One important reason for the
duration of untreated illness is that more than a third of
patients with a psychiatric disorder do not or only with
delay seek help from a mental health professional [8]. In
contrast, most children and adolescents are regularly seen
by general medical professionals for other reasons (e.g.,
primary care physician, pediatrician, or nurse) and/or by
school counselors (pedagogues, social workers, or some-
times psychologists) if they have behavioral or emotional
problems. These mainly non-mental health professionals
need screening instruments to detect whether or not a child
is in need for a general psychiatric evaluation (caseness)
and, in the event that a specific psychiatric disorder is
assumed, screeners for a particular disorder (e.g., ADHD,
psychosis). Furthermore, even mental health professionals
are in need for screens, if specialized, elaborate/sophisti-
cated and/or time-consuming assessments are considered,
e.g., for psychosis risk or autism [7, 9, 10].
Screenings are common in many areas of medicine, and
screeners are frequently employed for the detection of
psychiatric disorders [5, 9, 11]. However, in psychiatry,
screening instruments are often discredited for their poor
psychometric properties, such as too many false positives
(i.e., poor positive predictive value) or lack of adaptions for
certain age groups [9]. While some psychiatric disorders
may indeed be difficult to screen for, the most serious
problem is that reports on new screening instruments fre-
quently lack sufficient evaluation of crucial psychometric
properties that would be mandatory to judge their useful-
ness. This may have contributed to the bad reputation of
psychiatric screening instruments.
Psychometric properties of screeners
Generally, data on reliability and validity as well as norms
for the targeted population(s) is needed to evaluate its
appropriateness.
Reliability relates to the accuracy of measurement by a
screener—irrespective of whether or not it actually asses-
ses the targeted construct. Three complementary aspects of
reliability are distinguished: (1) Test–retest reliability
requires that a screener should measure whatever it mea-
sures consistently over time (note: the test–retest reliability
might well appear low when the screener measures a
fluctuating state rather than a trait condition and when the
condition itself has changed between test and retest
assessment). (2) Internal consistency demands that items of
the screener or its subscales are homogenous, i.e., measure
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the same construct(s). (3) If the screen is an interview,
inter-rater reliability evaluates the rate of agreement
between different raters [12, 13].
Validity relates to the degree to that a screener actually
measures what it is supposed to measure. Three compli-
mentary main aspects of validity are commonly required
for screening instruments: (1) of main interest for a clini-
cal-diagnostic application is the criterion validity; it is an
indicator of how well a screener’s result corresponds to an
individual result on a specified criterion [12, 13]. Thereby,
two aspects of criterion validity are distinguished in rela-
tion to the time between the assessment of screener and
criterion: (a) the degree to which the screener can identify
individuals who currently have any or a specific psychiatric
disorder (concurrent validity; requires nearly simultaneous
assessment of screener and criterion in the test construction
phase, while, later in practice, some time might pass
between screening and formal psychiatric assessment), and
(b) the extent to which an individual’s score on a screener
will accurately predict the individual’s future result such as
a psychiatric disorder (predictive validity; outcome crite-
rion will reveal only in future and is assessed considerably
later than screener) [12, 13]. (2) When the focus is less on
the result of a screen but rather on its score and the measure
of interest is less well defined than, for example, a formal
diagnosis but relates to a construct that is not directly
assessable (such as intelligence or personality characteris-
tics), the construct validity is assessed. It refers to the
extent to which screener scores correspond to scores of a
gold standard assessment by expert consensus (such as the
HAWIK in the assessment of IQ). One aspect of the con-
struct validity is the convergent validity, which is good
when the correlation between the screener and another
established assessment of the same construct is high. The
opposite aspect of construct validity is the discriminant
validity, which is high when screener scores do not cor-
relate with measures of other constructs [12]. For example,
scores of an ADHD screener should not be highly posi-
tively correlated to scores of scales assessing oppositional
defiant/conduct or emotional disorders. (3) The content
validity finally requests that the screening instrument
should measure all important aspects of the target condi-
tion, e.g., not only inattentiveness but also hyperactivity
and impulsivity when ADHD and not only the inattentive
subtype is targeted [12].
Taken together, besides producing (state) consistent
scores and results (reliability), a screener must also be
accurate with regard to content (validity). Generally reli-
ability is more easily established than validity, and reli-
ability is often first or exclusively described for
instruments. Thus, many screeners lack validity data,
which makes it difficult to know how clinically useful the
instrument is [12, 13]. An ideal screening instrument for
diagnostic purposes would demonstrate excellent concur-
rent (predictive) validity by (1) ruling in most if not all
patients with the target condition (diagnosis) while (2)
ruling out a considerable proportion of those without it.
To rule in most patients with the target condition, a
screener should generally possess a sensitivity approach-
ing 100 %, a negative diagnostic likelihood ratio
(LR) B0.1 that indicates a ‘large and often conclusive’
change from pre-screening to post-screening probability of
the absence of illness risk [14], and a positive predictive
value that is greatest in settings in which the prevalence
of the condition is highest, i.e., greater in clinical settings
than in community settings [15]. On the other hand, to
rule out a considerable proportion of patients without the
target condition, a screener should generally possess rea-
sonably high specificity and a positive diagnostic LR C5
that indicates at least a moderate increase in the pre-
screening to post-screening risk probability [14]. In many
studies evaluating screening instruments, e.g., for psy-
chosis risk [16], only sensitivity and specificity data are
described, while diagnostic likelihood ratios are rarely
provided, although these can be more easily interpreted
[cutoffs for ‘‘good’’ concurrent (predictive) validity exist]
and should, therefore, always be reported.
Additionally, the screener’s differential accuracy
should not be largely mediated by confounding condi-
tions, e.g., comorbid emotional or behavioral disorders
[17], but its items/components should possess good con-
tent, and convergent and/or criterion validity (i.e., indeed
measure the target condition) [13]. For example, when
tested alongside the gold standard of diagnosis in a clin-
ical interview, the final screener result (e.g., determined
by a cutoff score) should not only correspond to the
interview result but also each single item of the screener
should highly correlate with their respective interview
counterparts (both are aspects of convergent validity in
dimensional assessments or of criterion validity when
presence of symptoms is rated) [13]. Further, all aspects
and not only parts of the target condition should be
assessed by the screening tool (content validity). These
criteria are rarely addressed in studies evaluating screen-
ing instruments.
Last but not least for clinical purposes and the evalua-
tion of the mental state of individual patients, norms or
cutoffs should be provided that allow the evaluation of an
individual performance against that of a similar group. To
improve the population fit, screener should be adopted to
the overall purpose (e.g., screening for psychiatric caseness
in the general population vs. screening for a specific con-
dition in a clinical population) or to different groups (e.g.,
separate norms for age groups, gender, and/or other
potentially influential sociodemographic characteristics)
[12].
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Conclusions
Many studies on screening instruments lack the appropriate
assessment of relevant psychometric properties. However,
before studying psychometric properties, the purpose (e.g.,
caseness in general or a specific psychiatric diagnosis) and
setting (e.g., general population/school, primary care or
mental health services including the expected develop-
mental stage of the recipients) of a screening should be
clarified. Most screeners are not useful for all purposes
(e.g., for caseness and a specific disorder). Consequently,
psychometric properties should be studied in appropriate
populations of adequate sample size using pre-defined (!)
cutoffs for reliability and validity criteria (e.g., diagnostic
likelihood ratios) that distinguish a useful from a useless
screening instrument. Although it may be difficult to
develop good screeners for all situations and conditions in
child and adolescent psychiatry, and many studies of
potential screeners are so far inappropriate, careful research
on screening instruments is mandatory to improve com-
prehensive and early detection of psychiatric conditions in
children and adolescents—in particular during times of
increasingly tighter resources.
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